Maxime Delrue

413 total citations
12 papers, 184 citations indexed

About

Maxime Delrue is a scholar working on Internal Medicine, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Maxime Delrue has authored 12 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Internal Medicine, 5 papers in Infectious Diseases and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Maxime Delrue's work include Venous Thromboembolism Diagnosis and Management (8 papers), COVID-19 Clinical Research Studies (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Maxime Delrue is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (8 papers), COVID-19 Clinical Research Studies (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Maxime Delrue collaborates with scholars based in France, Belgium and Canada. Maxime Delrue's co-authors include Virginie Siguret, Alain Stépanian, Bruno Mégarbane, Sébastian Voicu, Étienne Gayat, Philippe Bonnin, Emmanuel Curis, Benjamin G. Chousterman, D. Sène and Pascale Gaussem and has published in prestigious journals such as CHEST Journal, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

Maxime Delrue

11 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maxime Delrue France	7	97	69	49	46	37	12	184
Valeria Coluccio Italy	6	52 0.5×	51 0.7×	56 1.1×	7 0.2×	27 0.7×	16	196
Gloria Pérez‐Rus Spain	7	80 0.8×	20 0.3×	5 0.1×	26 0.6×	105 2.8×	14	214
M. Biosca Spain	8	19 0.2×	23 0.3×	16 0.3×	44 1.0×	10 0.3×	23	154
S. Humbert France	7	21 0.2×	20 0.3×	26 0.5×	38 0.8×	5 0.1×	27	171
Milad Gholizadeh Mesgarha Iran	7	52 0.5×	8 0.1×	11 0.2×	10 0.2×	21 0.6×	19	127
Martin Mehrländer Germany	3	70 0.7×	36 0.5×	11 0.2×	2 0.0×	47 1.3×	4	146
Andreas Czwalinna Germany	9	35 0.4×	62 0.9×	33 0.7×	12 0.3×	248 6.7×	16	323
Kate Milne United Kingdom	4	148 1.5×	54 0.8×	9 0.2×		20 0.5×	6	196
Mark Smith United Kingdom	6	10 0.1×	18 0.3×	12 0.2×	51 1.1×	39 1.1×	8	210
Amélie Chabrol France	5	27 0.3×	11 0.2×	11 0.2×	20 0.4×	42 1.1×	6	203

Countries citing papers authored by Maxime Delrue

Since Specialization

Citations

This map shows the geographic impact of Maxime Delrue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Delrue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Delrue more than expected).

Fields of papers citing papers by Maxime Delrue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Delrue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Delrue. The network helps show where Maxime Delrue may publish in the future.

Co-authorship network of co-authors of Maxime Delrue

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Delrue. A scholar is included among the top collaborators of Maxime Delrue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Delrue. Maxime Delrue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Crichi, Benjamin, et al.. (2025). Reduced-dose versus full-dose apixaban for extended treatment of cancer-associated venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Thrombosis Research. 256. 109505–109505.

Siguret, Virginie, et al.. (2025). Cerebral Venous Thrombosis and Nitrous Oxide Intoxication: Report of Two Cases and Review of the Literature. Brain and Behavior. 15(3). e70394–e70394. 1 indexed citations

Stépanian, Alain, Peggy Reiner, Maxime Delrue, et al.. (2023). Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients. Journal of Stroke. 25(1). 126–131. 7 indexed citations

Delrue, Maxime, Alain Stépanian, Sébastian Voicu, et al.. (2022). No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event. CHEST Journal. 162(1). 226–229. 5 indexed citations

Delrue, Maxime, L Chevillard, Alain Stépanian, et al.. (2022). Case series of massive direct oral anticoagulant ingestion—Treatment and pharmacokinetics data. European Journal of Clinical Investigation. 52(6). e13746–e13746. 6 indexed citations

Lafuente‐Lafuente, Carmelo, Georges Jourdi, J. Le Guen, et al.. (2022). Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients. Thrombosis and Haemostasis. 123(4). 402–414. 12 indexed citations

Delrue, Maxime, et al.. (2021). Foot ischemia related to essential thrombocytemia and atherosclerosis. JMV-Journal de Médecine Vasculaire. 46(3). 123–128. 2 indexed citations

Coutrot, Maxime, Maxime Delrue, Bérangère S. Joly, & Virginie Siguret. (2021). Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case report. European Heart Journal - Case Reports. 5(6). ytab206–ytab206. 1 indexed citations

Siguret, Virginie, Sébastian Voicu, Maxime Delrue, et al.. (2020). Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?. Thrombosis Research. 195. 74–76. 68 indexed citations

10.

Voicu, Sébastian, Maxime Delrue, Benjamin G. Chousterman, et al.. (2020). Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.. PubMed. 24(17). 9161–9168. 22 indexed citations

11.

Delrue, Maxime, Virginie Siguret, Bérangère S. Joly, et al.. (2020). von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate‐to‐severe COVID‐19 patients. British Journal of Haematology. 192(6). 1097–1100. 27 indexed citations

12.

Jourdi, Georges, Maxime Delrue, Alain Stépanian, et al.. (2019). Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants. Thrombosis Research. 184. 86–91. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact